The p53-abnormal group accounts for the vast majority of carcinosarcomas (73.9%), which commonly arise from serous ECs [33], and almost half of clear-cell ECs (42.5%) [32] (Table 3). The gene discussed is TP53; the disease is carcinosarcoma.